US5215899A
(en)
*
|
1989-11-09 |
1993-06-01 |
Miles Inc. |
Nucleic acid amplification employing ligatable hairpin probe and transcription
|
US6074818A
(en)
*
|
1990-08-24 |
2000-06-13 |
The University Of Tennessee Research Corporation |
Fingerprinting of nucleic acids, products and methods
|
US5683985A
(en)
*
|
1991-04-18 |
1997-11-04 |
The Salk Institute For Biological Studies |
Oligonucleotide decoys and methods relating thereto
|
DE4216134A1
(de)
*
|
1991-06-20 |
1992-12-24 |
Europ Lab Molekularbiolog |
Synthetische katalytische oligonukleotidstrukturen
|
CA2118913C
(fr)
*
|
1991-09-13 |
2008-08-19 |
Donald Leonard Nicholas Cardy |
Essai d'extension d'acides nucleiques
|
DE4132133A1
(de)
*
|
1991-09-26 |
1993-04-01 |
Boehringer Mannheim Gmbh |
Verfahren zur spezifischen herstellung von ribonukleinsaeuren
|
DE4213029A1
(de)
*
|
1991-09-26 |
1993-04-01 |
Boehringer Mannheim Gmbh |
Verfahren zur spezifischen vervielfaeltigung von nukleins aeuresequenzen
|
US5424413A
(en)
*
|
1992-01-22 |
1995-06-13 |
Gen-Probe Incorporated |
Branched nucleic acid probes
|
WO1994003624A1
(fr)
*
|
1992-08-04 |
1994-02-17 |
Auerbach Jeffrey I |
Procedes d'amplification isothermique de molecules d'acide nucleique
|
DE4236708A1
(de)
*
|
1992-10-30 |
1994-05-05 |
Bayer Ag |
Spezifische Gensonden und Verfahren zur Diagnostik von Candida albicans
|
GB2273932A
(en)
*
|
1992-11-24 |
1994-07-06 |
Stiefel Laboratories |
Stable oligonucleotides
|
DE4302459A1
(de)
*
|
1993-01-29 |
1994-08-04 |
Bayer Ag |
Sulfocumarinhaltige Nukleotide und deren Verwendung in Nachweisverfahren für Nukleinsäuren
|
FR2703053B1
(fr)
*
|
1993-03-26 |
1995-06-16 |
Genset Sa |
Oligonucleotides agrafes et semi-agrafes, procede de preparation et applications .
|
IL105894A
(en)
*
|
1993-06-03 |
1997-02-18 |
Asher Nathan |
Method for the detection of nucleic acid sequence by using a detection ensemble and an amplification ensemble
|
DE4338119A1
(de)
*
|
1993-11-08 |
1995-05-11 |
Bayer Ag |
Spezifische Gensonden und Verfahren zum quantitativen Nachweis von methicillinresistenten Staphylococcen
|
CA2185239C
(fr)
*
|
1994-03-16 |
2002-12-17 |
Nanibhushan Dattagupta |
Amplification d'acide nucleique par deplacement de la souche isotherme
|
DE4421901A1
(de)
*
|
1994-06-23 |
1996-01-04 |
Bayer Ag |
Ein DNA-Schnelltest zum Nachweis von chinolonresistenten Staphylococcus aureus Erregern in klinischem Probenmaterial
|
FR2721945B1
(fr)
*
|
1994-07-04 |
1996-10-18 |
David Fabrice |
Accroissement genique, un procede d'amplicication genique isotherme et ses applications
|
FR2723591B1
(fr)
*
|
1994-08-10 |
1996-09-20 |
Cis Bio Int |
Methode d'amplification et/ou de detection d'une sequence d'acide nucleique, reactif de detection et ses applications.
|
DE4428651C1
(de)
*
|
1994-08-12 |
1996-02-29 |
Inst Molekulare Biotechnologie |
Verfahren zur Herstellung und Amplifikation von Nukleinsäuren
|
US5665545A
(en)
*
|
1994-11-28 |
1997-09-09 |
Akzo Nobel N.V. |
Terminal repeat amplification method
|
AU724922B2
(en)
*
|
1995-06-07 |
2000-10-05 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
US6720140B1
(en)
|
1995-06-07 |
2004-04-13 |
Invitrogen Corporation |
Recombinational cloning using engineered recombination sites
|
US6964861B1
(en)
|
1998-11-13 |
2005-11-15 |
Invitrogen Corporation |
Enhanced in vitro recombinational cloning of using ribosomal proteins
|
US5914229A
(en)
*
|
1996-06-14 |
1999-06-22 |
Sarnoff Corporation |
Method for amplifying a polynucleotide
|
US6025133A
(en)
*
|
1996-12-30 |
2000-02-15 |
Gen-Probe Incorporated |
Promoter-sequestered oligonucleoside and method of use
|
CA2307016A1
(fr)
|
1997-10-24 |
1999-05-06 |
Life Technologies, Inc. |
Clonage recombinatoire au moyen d'acides nucleiques possedant des sites de recombinaison
|
AU774643B2
(en)
|
1999-03-02 |
2004-07-01 |
Invitrogen Corporation |
Compositions and methods for use in recombinational cloning of nucleic acids
|
DE19916929A1
(de)
|
1999-04-15 |
2000-10-19 |
Bayer Ag |
Ein automatisierbarer Schnelltest zum Nachweis von Krebserkrankungen auf der Basis von Telomerase(hTC) mRNA mit spezifischen Primern und Sonden
|
US7198924B2
(en)
|
2000-12-11 |
2007-04-03 |
Invitrogen Corporation |
Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
|
US8137911B2
(en)
|
2001-05-22 |
2012-03-20 |
Cellscript, Inc. |
Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
|
US7838270B2
(en)
|
2001-05-22 |
2010-11-23 |
The University Of Chicago |
Target-dependent transcription using deletion mutants of N4 RNA polymerase
|
WO2002103052A1
(fr)
*
|
2001-06-15 |
2002-12-27 |
Quiatech Ab |
Sonde amplifiable
|
US20040197802A1
(en)
|
2002-11-21 |
2004-10-07 |
Dahl Gary A. |
Methods for using primers that encode one strand of a double-stranded promoter
|
ATE469984T1
(de)
|
2003-12-01 |
2010-06-15 |
Life Technologies Corp |
Rekombinationsstellen enthaltende nukleinsäuremoleküle und verfahren zur verwendung davon
|
EP1882036B1
(fr)
|
2005-05-17 |
2012-02-15 |
Ozgene Pty Ltd |
Système de clonage séquentiel
|
WO2009006438A2
(fr)
|
2007-06-29 |
2009-01-08 |
Epicentre Technologies Corporation |
Adn de copie et arn sens
|
EP2600901B1
(fr)
|
2010-08-06 |
2019-03-27 |
ModernaTX, Inc. |
Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale
|
ES2737960T3
(es)
|
2010-10-01 |
2020-01-17 |
Modernatx Inc |
Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos
|
AU2012236099A1
(en)
|
2011-03-31 |
2013-10-03 |
Moderna Therapeutics, Inc. |
Delivery and formulation of engineered nucleic acids
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP3682905B1
(fr)
|
2011-10-03 |
2021-12-01 |
ModernaTX, Inc. |
Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations
|
EP2791160B1
(fr)
|
2011-12-16 |
2022-03-02 |
ModernaTX, Inc. |
Compositions de mrna modifiés
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US9303079B2
(en)
|
2012-04-02 |
2016-04-05 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
AU2013243948A1
(en)
|
2012-04-02 |
2014-10-30 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins associated with human disease
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
EP4074834A1
(fr)
|
2012-11-26 |
2022-10-19 |
ModernaTX, Inc. |
Arn à terminaison modifiée
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
CN103383355B
(zh)
*
|
2013-07-12 |
2015-09-30 |
华南师范大学 |
基于非酶扩增及电化学发光原理的microRNA检测方法
|
WO2015048744A2
(fr)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucléotides codant des polypeptides de modulation immunitaire
|
CA2926218A1
(fr)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides codant pour un recepteur de lipoproteines de faible densite
|
WO2018031751A1
(fr)
*
|
2016-08-12 |
2018-02-15 |
The Regents Of The University Of California |
Constructions et procédés d'amplification de signaux.
|